- Home
- NCTY vs DTIL Comparison
NCTY vs DTIL Comparison
Compare NCTY & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NCTY | DTIL |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.7M | 97.7M |
| IPO Year | 2004 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NCTY | DTIL |
|---|---|---|
| Price | $6.96 | $4.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $47.00 |
| AVG Volume (30 Days) | 35.2K | ★ 269.0K |
| Earning Date | 03-27-2015 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,403,864.00 | $698,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $34.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.95 | $3.75 |
| 52 Week High | $17.83 | $8.82 |
Technical Indicators
Market Signals| Indicator | NCTY | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 41.63 |
| Support Level | $6.40 | $3.75 |
| Resistance Level | $7.16 | $4.19 |
| Average True Range (ATR) | 0.48 | 0.27 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 55.22 | 39.65 |
Price Performance
Historical ComparisonAbout NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.